Movement Disorders
154
26
33
70
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Research Maturity
70 completed trials (45% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.2%
8 terminated out of 154 trials
89.7%
+3.2% vs benchmark
3%
4 trials in Phase 3/4
14%
10 of 70 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 70 completed trials
Clinical Trials (154)
Validating a New Machine-Learned Accelerometer Algorithm Using Doubly Labeled Water
Non-invasive BCI-controlled Assistive Devices
Botulinum Toxin for the Treatment of Involuntary Movement Disorders
Deep Brain Stimulation (DBS) MatchMaker
Physiological Investigations of Movement Disorders
Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's Disease Patients
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
Dyadic Mindfulness for People With Parkinson's Disease and Their Caregivers
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
A Multicenter Pediatric Deep Brain Stimulation Registry
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS
Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders
Leg Stretching Using an Exoskeleton on Demand for People With Spasticity
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
Investigation of the Effect of Movement Mobilization Concept on Sensory, Pain, Muscle Activation in Patients With Knee Osteoarthritis
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures